Teva's Plan B request denied by government
U.S. Department of Health and Human Services Secretary Kathleen Sebelius announced that Teva's Plan B morning-after contraceptive pill will still require a prescription for girls 16 years of age and under.
Teva's Plan B request denied by government
David Sell
U.S. Department of Health and Human Services Secretary Kathleen Sebelius announced that Teva's Plan B morning-after contraceptive pill will still require a prescription for girls 16 years of age and under.
The HHS statement is here.
Popular Posts
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.
Reach David at dsell@phillynews.com.
David Sell
Search this blog:
Blog Roll
- Adolor
- Almac
- AmerisourceBergen
- AstraZeneca
- Auxilium
- Bayer
- Celgene
- Cephalon
- Endo
- GlaxoSmithKline
- Johnson & Johnson
- Kensey Nash
- Lannett
- Merck
- Pfizer
- Roche
- Sanofi-aventis
- Shire
- Stryker
- Synthes
- Teva
- ViroPharma
- West
- Centers for Disease Control and Prevention
- Centers for Medicare and Medicaid
- Clinical Trials
- Food and Drug Administration
- Office of Inspector General, Health and Human Services
- OIG Most-wanted list of fugitives
- Securities and Exchange Commission/Edgar filings
- U.S. Attorney's Office/Eastern Pennsylvania, health-care fraud
- U.S. Department of Health and Human Services
- BIO
- Jersey Association of Medical Equipment Services
- Pennsylvania Association of Medical Suppliers
- Pharmaceutical Research and Manufacturers of America
- Science Center
- American Health Lawyers Association
- Drug and Device Law
- Orange Book blog
- Taxpayers Against Fraud
- Bio Century
- Bio Space
- Cafe Pharma
- Financial Times
- In The Pipeline
- Monday Morning
- New York Times/Prescriptions
- Pharma Live
- Pharma Marketing
- Pharmalot
- The Placebo Effect
- Wall Street Journal/Health blog
Classifieds:
Site Services:
Partners: